All Posts By

Smartkarma Daily Briefs

Smartkarma The Investment Intelligence Platform

Daily Brief ECM: Aequitas: AP Memory Technology GDR Offering – Well Flagged US$422m GDR and more

By | Daily Briefs, ECM

In today’s briefing:

  • Aequitas: AP Memory Technology GDR Offering – Well Flagged US$422m GDR
  • Tinci Materials H Share Listing: The Investment Case
  • Jio Platforms Pre-IPO: Tearsheet
  • Aequitas: DST Sustainable Pre-IPO – Strong Topline Growth, GIC and Blackrock Are Shareholders
  • U.S. IPO Recap Week of 10/9/2026
  • IPO Rating: Iambic Therapeutics, Inc.
  • IPO Databook: Suzhou Dongshan Precision Manufacturing (HK) – Oct 2026
  • Aequitas: Suzhou Dongshan Precision A/H Listing – PHIP Updates and Thoughts on A/H Premium
  • Aequitas: Zetwerk IPO – Order Book Strength and Scale, but Losses and Cash Burn Persist
  • DTS IPO Bookbuilding Results Analysis


Aequitas: AP Memory Technology GDR Offering – Well Flagged US$422m GDR

By Akshat Shah

  • AP Memory Technology (6531 TT)  is raising around US$422m, selling 14.8m shares via a GDR offering. Proceeds will be used to procure raw materials overseas and fund working capital.
  • Similar to previous GDR listings, the firm has undergone a long drawn out process prior to launching the deal, having to jump through a number of board/shareholder/regulatory approval loops.
  • In this note, we run the deal through our ECM framework and comment on deal dynamics.

Tinci Materials H Share Listing: The Investment Case

By Arun George

  • Guangzhou Tinci Materials Technology (TINCI HK), the world’s largest lithium-ion battery electrolyte supplier, is premarketing an H-share offering, which could raise about US$400–500 million.
  • It makes electrolytes and their core compositions (LiPF6, LiFSI, and additives), cathode materials, and battery adhesives for EV, energy storage (ESS), and consumer battery makers.
  • The investment case is cautious: Tinci is an integrated, low-cost leader in a growing market, but 1H26 earnings reflect a price spike, revenue is concentrated, and the FCF turned negative.

Jio Platforms Pre-IPO: Tearsheet

By Ke Yan, CFA, FRM

  • Jio Platforms, a digital connectivity provider, has filed its draft prospectus. The 19 bookrunners include international banks MS, UBS, BOA, Citi, CLSA, GS, HSBC, Jefferies, JPM and BNP Paribas.
  • We look at the company’s two core businesses, mobile connectivity and fixed broadband.
  • We then look at the company’s financial profile, cash generation, leverage and pre-IPO investor backing.

Aequitas: DST Sustainable Pre-IPO – Strong Topline Growth, GIC and Blackrock Are Shareholders

By Hong Jie Seow

  • DST Sustainable Technology Shenzhen Co Ltd (2659720D HK) DST Sustainable Technology is looking to raise US$400m in its upcoming Hong Kong IPO.
  • DST Sustainable Technology (Shenzhen) is a leading provider of intelligent logistics electric vehicle (EV) management solutions in China.
  • In this note, we look at the company’s past performance.

U.S. IPO Recap Week of 10/9/2026

By IPO Prophet

  • One qualifying IPO priced and began trading this week: TRex Bio raised $116.7 million.
  • It priced at the low end of its range, opened below issue, recovered to a double-digit intraday premium and closed exactly at the $14.00 issue price.
  • The result kept the financing window open for biotech, but it did not demonstrate broad risk appetite.

IPO Rating: Iambic Therapeutics, Inc.

By IPO Prophet

  • ✓ IPO Prophet Rating: 7.83/10 🏦 Deal Quality & Underwriters: 8.35/10 Iambic Therapeutics is offering 9.38 million all-primary shares at $15.00–$17.00, representing approximately $150 million at the midpoint and an implied market capitalization of roughly $758 million.
  • The Nasdaq transaction is expected to price October 15 under the ticker IAM.
  • J.P. Morgan, Jefferies, BofA Securities and Citigroup provide a strong healthcare-focused underwriting syndicate capable of reaching both specialist biotechnology investors and broader institutions. 

IPO Databook: Suzhou Dongshan Precision Manufacturing (HK) – Oct 2026

By αSK IPO Databooks

  • Suzhou Dongshan Precision Manufacturing Co., Ltd. manufactures PCBs, precision components, touch panels, LCMs, and optical transceivers globally.
  • The company was ranked as the third-largest PCB supplier in 2025 and seventh among global optical transceiver suppliers.
  • The company reported revenue of RMB40,124,859 thousand for 2025, but profit for the year decreased by 44.8% in 2024. Net current assets also decreased significantly by December 31, 2025.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Aequitas: Suzhou Dongshan Precision A/H Listing – PHIP Updates and Thoughts on A/H Premium

By Sumeet Singh

  • Suzhou Dongshan Precision A (002384 CH) (SDPM), a global PCB and other component provider, aims to raise up to US$3bn in its H-share listing.
  • SDPM was the third largest PCB supplier and seventh largest global transceiver supplier by revenue in 2025, according to CIC.
  • We have looked at the company’s past performance in our previous note. In this note, we talk about the recent updates and likely A/H premium.

Aequitas: Zetwerk IPO – Order Book Strength and Scale, but Losses and Cash Burn Persist

By Akshat Shah

  • Zetwerk Manufacturing Businesses (1834044D IN, ZMBL) is looking to raise around US$525m in its India IPO, having upsized from an earlier estimated size of about US$440m.
  • ZMBL is a technology-led manufacturing platform for industrial and consumer goods in India and globally,built with exposure to renewable energy, power infrastructure, electronics, defence and industrial products.
  • In this note, we look at the firm’s past performance as of the updated RHP filings.

DTS IPO Bookbuilding Results Analysis

By Douglas Kim

  • DTS finalized its IPO price at 18,500 won (high end of IPO price range). A total of 2,381 institutions participated in the demand forecasting. Demand ratio was 983.98 to 1. 
  • Based on the finalized offering price, the total proceeds from the IPO amount to approximately 41.2 billion won, and the company’s expected market capitalization post-listing is around 275.3 billion won.
  • My base case valuation of DTS is a target price 29,360 won per share, which is 59% higher than the IPO price (18,500 won). 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Event-Driven: Cleanaway (CWY AU): EQT Deal on Track and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Cleanaway (CWY AU): EQT Deal on Track, but the Vote Won’t Be a Formality
  • [Japan Partial Tender] Maki-San Threatens BASE (4477 JP) Tender – Financial Engineering Risk Rises
  • A Tender Offer of 19% Stake in Hanwha Machinery & Service Holdings By Kim Dong-Seon
  • EBOS (EBO AU): Still Under The Hammer Post Sigma/Chemist Warehouse Merger
  • AkzoNobel / Axalta: EU Remedies Take Shape
  • StubWorld: Stay With Colowide (7616 JP); Bullet Dodged On Genting (GENT MK)
  • Strategic Reviews and Takeover Proposals: Updates on RYAM, MTY, MDT, and More
  • Weekly Update (IDT, MSGS, MSGR)


Cleanaway (CWY AU): EQT Deal on Track, but the Vote Won’t Be a Formality

By Arun George

  • EQT has reconfirmed its A$3.13 offer (A$3.095 net of dividend) for Cleanaway Waste Management (CWY AU) three times. Financing is well covered, and a SID looks likely.
  • Shares fell 3.6% to A$2.66 today, likely reflecting sell-the-news profit-taking, a third exclusivity extension, growing institutional opposition and the 22 October AGM overhang.
  • The scheme vote should pass, as confirmed dissent (10.3%) is insufficient to block it, but industry funds (14%) joining and the AGM spill risk make it contested, not a formality.

[Japan Partial Tender] Maki-San Threatens BASE (4477 JP) Tender – Financial Engineering Risk Rises

By Travis Lundy

  • On Friday 9 October, largest BASE Inc (4477 JP) shareholder MAKI Hiroyuki who is also President and CEO Melco Holdings (6676 JP) (a.k.a. Buffalo Inc), announced his new larger stake.
  • Or part of it. He got to 23.32% by 2 October. I expect it’s 26-27% as of now, but could be slightly higher. He also released a change in purpose.
  • That change suggests substantial disagreement with and distrust of management. It threatens a Tender Offer to get over 30% (which he says he intends). Interesting times lie ahead. 

A Tender Offer of 19% Stake in Hanwha Machinery & Service Holdings By Kim Dong-Seon

By Douglas Kim

  • Kim Dong-seon (third son of Hanwha Group Chairman Kim Seung-youn) has launched a tender offer of a 19% stake in Hanwha Machinery & Service Holdings (0220W0 KS) (HMSH).
  • The tender offer is for 16.06 million common shares at 8,000 won per share, running from 12 October to 2 November. 
  • I have a positive view on this tender offer and on HMSH whose share price fell excessively post split and Kim Dong-seon is trying to capitalize on this price decline.

EBOS (EBO AU): Still Under The Hammer Post Sigma/Chemist Warehouse Merger

By David Blennerhassett

  • EBOS Group (EBO AU), a healthcare and animal-care distribution group, is currently trading around a six-year low.
  • That seems a tad harsh with bottom-line earnings up 39% over that timeframe. And a trailing yield of ~6.5%, well above peers.
  • The Sigma Healthcare (SIG AU)/Chemist Warehouse combination remains a structural competitive concern. But right here, I’d be surprised if (potential) suitors are not running a ruler over EBOS.

AkzoNobel / Axalta: EU Remedies Take Shape

By Jesus Rodriguez Aguilar

  • EU clearance appears increasingly likely following reports of a proposed vehicle-refinish divestiture, although the scope of the remedy, disposal proceeds and impact on synergies remain undisclosed.
  • Our revised synergy DCF values the $600m annual savings programme at €3.61bn after a 25% execution-risk discount. Losing $50–100m of annual savings would reduce that valuation by €0.33–0.66bn.
  • AkzoNobel’s Asian disposals have secured attractive multiples, but the merger spread is just 0.2%. We see insufficient compensation for the remaining risks and would not initiate an arbitrage position.

StubWorld: Stay With Colowide (7616 JP); Bullet Dodged On Genting (GENT MK)

By David Blennerhassett

  • Stick with restaurant group Colowide Co Ltd (7616 JP), despite the elevated implied stub and NAV discount. And Genting Bhd (GENT MK) craters on rights issue plan.
  • Preceding my comments on Colowide and Genting are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Strategic Reviews and Takeover Proposals: Updates on RYAM, MTY, MDT, and More

By Special Situation Investments

  • RYAM’s strategic review nears completion with potential 60%+ upside; stock dropped 25% recently, creating entry opportunity.
  • MTY Food Group ends strategic review without sale, raises dividend 35%, reinstates buybacks, considers small issuer bid.
  • EQT reconfirms A$3.13/share offer for CWY; OFX deal stalled at financing stage, Forager discloses 5.4% stake.

Weekly Update (IDT, MSGS, MSGR)

By Richard Howe

  • The S&P 500 is sitting near 7,800, a record high.
  • At the same time, the 25-day average of new lows on the NYSE has spiked to levels we last saw in the April 2025 selloff.
  • The index is at an all-time high while a lot of individual stocks are trading like it’s a bear market.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Equity Bottom-Up: Gemini at Work 2026. Impressive Enterprise AI Strategy Is Revealed. Key Takeaways & Full Transcript and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Gemini at Work 2026. Impressive Enterprise AI Strategy Is Revealed. Key Takeaways & Full Transcript
  • USD 10bn Catalyst: Japan Post’s Mega-Monetisation & Mitsui Fudosan’s Ascension
  • BBNI IJ: When Credit Growth Outruns Earning Power
  • Hong Leong Asia Ltd. (SGX: H22): Initiation Research (6 October 2026)
  • SK HYNIX (000660 KS / SKHY US): The Solidigm Confusion Is a Gift. Average Down.
  • Coway (021240): Haze Beneficiary
  • Micron sells AI memory before the year starts, and each bit takes three times the wafer
  • Coupang (CPNG US): A Temporary Glitch?
  • Japan: Relative Value Opportunities and Pair Trades (13 Oct 2026)
  • Furuno Electric (6814 JP): Good Quarter, Better Plan


Gemini at Work 2026. Impressive Enterprise AI Strategy Is Revealed. Key Takeaways & Full Transcript

By William Keating

  • Google’s latest frontier model, Argon, delivers frontier performance and complex workflows across knowledge work, real-world software engineering, and cybersecurity defense.
  • The Chrome team (3 billion users) has been using Argon to refactor features that span millions of lines of code. Normally, this would take months. They’ve done it in weeks
  • Gemini is the agent. The model underneath is a separate choice, and it is yours. From Argon at the frontier to Flash for speed and to the latest Claude models. 

USD 10bn Catalyst: Japan Post’s Mega-Monetisation & Mitsui Fudosan’s Ascension

By Jacob Cheng

  • Japan Post is monetizing a JPY 1.6 trillion portfolio, unlocking JPY 700bn in gains through private funds under activist pressure, creating a generational asset pipeline.
  • Mitsui Fudosan is uniquely positioned to dominate these mandates, expanding asset management fees and driving ROE toward 10% via aggressive share buybacks without balance sheet bloat.
  • Accelerated fund launches offer massive upside, while Bank of Japan rate shocks pose limited downside due to resilient fixed-rate corporate debt and robust Tokyo office rental growth.

BBNI IJ: When Credit Growth Outruns Earning Power

By Defriansyah Has

  • Bottom line: BBNI is the only one of Indonesia’s four largest banks below book value (0.76x versus BMRI 1.34x, BBRI 1.48x, BBCA 2.76x); we rate it BULLISH, moderate-to-low conviction.
  • What the price implies: at Rp3,430, a perpetual ROE of about 9.9% — below FY2025 normalized ROE of 12.89% and the 1H26 run-rate of roughly 12.7%–12.9%.
  • Why conviction is low: funding, margin and capital pressure has not been shown to stop; scenarios are model assumptions, not forecasts, and do not show earning power has stabilized.

Hong Leong Asia Ltd. (SGX: H22): Initiation Research (6 October 2026)

By Privium Fund Management

  • Hong Leong Asia (HLA) is a Singapore holding company with two key drivers: a 48.70% controlling stake in NYSE-listed China Yuchai International (“CYI”), one of China’s main diesel engine makers, and an integrated building materials business in Singapore and Malaysia.
  • Trailing twelve-month (TTM) PATMI reached S$148.7m to 30 June 2026, more than double FY2023, as engine volumes, data centre demand and Singapore’s construction upcycle lifted both segments.
  • About 47% of HLA’s market value is covered by its listed stakes in China Yuchai and BRC Asia at market.

SK HYNIX (000660 KS / SKHY US): The Solidigm Confusion Is a Gift. Average Down.

By Mo Aziz

  • Solidigm IPO rumours have hurt: ₩129tn of MCAP erased since 26 Sep. Investors clearly dislike it; and management adding no value by stating “nothing decided yet.”
  • Our math: a US$100bn IPO moves value −1.7% to +1.1%; even a fire-sale costs 6.2%. Abandonment recovers ~₩176,000 per share.
  • Maintain BULLISH, FV ₩2,700,000 (+60%). At 6.2x FY27E P/E, average down. Cyclicals are bought when the bad news is out.

Coway (021240): Haze Beneficiary

By Henry Soediarko

  • Coway Co Ltd (021240 KS) counts around 35% of its revenue from Southeast Asia particularly Malaysia and Thailand, where it recorded high growth, offsetting the mature domestic Korean market. 
  • Due to the current haze season that may last until November, Coway’s revenues are supposed to be carried up and its share price may see multiple expansion as well. 
  • At <2x PBV, 11x PER and 8x EV/EBITDA, a defensive stock that is committed to Value Up program, including cancellations of treasury and maintaining dividends, it sounds like a bargin. 

Micron sells AI memory before the year starts, and each bit takes three times the wafer

By The Physical Layer

  • Micron, one of three companies that make the stacked memory beside AI chips, commits most of each year’s supply of it before that year starts.
  • By Micron’s own account, each unit of it uses about three times the silicon of ordinary computer memory.
  • So while AI memory grows faster than the rest, it takes silicon away from the ordinary memory in phones, laptops and servers, and keeps that short too.

Coupang (CPNG US): A Temporary Glitch?

By Michael Fritzell

  • In the book Free Capital, the private investor Vernon talks about his strategy of buying growth stocks when they encounter “glitches” – temporary market overreactions to negative events.
  • I try to catch that company when nobody wants it, while it is still working through its problems” – VernonSouth Korean e-commerce operator Coupang (CPNG US – US$26 billion) is a test of that idea.
  • The stock sold off after its cybersecurity breach in November 2025.

Japan: Relative Value Opportunities and Pair Trades (13 Oct 2026)

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlights: In Japan, currently two pair trade opportunities persist across two sectors.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

Furuno Electric (6814 JP): Good Quarter, Better Plan

By Mark Chadwick

  • 2QFY2/27 OP of ¥7.2bn beat our forecast by 32% and the Street by 31%; excluding FX, 1H OP still grew c.16%.
  • The FY2030 plan targets ¥180bn of sales and a 15%+ OPM, with services and defence delivering nearly half of the growth.
  • We raise FY2/27–29E OP by 8–12% and our target to ¥8,870 (from ¥7,770); we remain Bullish.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Macro: Cross-Asset Rotations: China and more

By | Daily Briefs, Macro

In today’s briefing:

  • Cross-Asset Rotations: China, Asia FX, Commodities, and More
  • Oil futures: Crude eases as Trump rules out pre-election strike on Iran
  • Base Oils and Lubricants: Weekly Global Market Review – 9 Oct ’26
  • US Housing: The Lingering Curse of Poor Affordability Intensifies
  • Anatomy of a Canadian Bear
  • Middle East FX, October 9nd 2026
  • CX Daily: Yuan’s Global Role Is Expanding Beyond Trade, StanChart Execs Say
  • Morning Market Notes: Will The U.S.-Russia Diesel Deal Happen? Maybe Not
  • Oil futures: Crude higher as Mideast risk offsets Russia diesel release
  • The First-Mile View on Commodities Making News (12 Oct 2026)


Cross-Asset Rotations: China, Asia FX, Commodities, and More

By Damanick Dantes, CMT

  • Participation is broadening across markets as cap-weighted U.S. leadership narrows to a handful of stocks.
  • We stay invested in core trends and see room for emerging opportunities like China ADRs, which saw an upgrade. See our sample portfolio.
  • For Asia-focused investors, the dollar’s softening is concentrated against EM Asia currencies and the carry complex despite the dollar index’s bias against EUR.

Oil futures: Crude eases as Trump rules out pre-election strike on Iran

By Quantum Commodity Intelligence

  • Crude oil futures eased slightly on Friday after US President Donald Trump ruled out immediate attacks on Iran, while Hurricane Isaias has taken a more easterly direction and away from the Louisiana onshore oil hub.
  • Front-month Dec26 ICE  Brent futures were 0.2% lower at $104.09/b (2101 BST), while Nov26 NYMEX WTI was at $91.38/b , down 0.1% versus Thursday’s settle.
  • President Donald Trump said on Thursday the US would not attack Iran before the midterm elections, tempering rising crude oil prices after several US media reports had flagged that renewed military strikes were looking imminent.

Base Oils and Lubricants: Weekly Global Market Review – 9 Oct ’26

By Iain Pocock

  • Spare base oils supply is thin across major regions, leaving little room to absorb disruption from storms, outages or maintenance

  • Asia cleared a swathe of supply in the third quarter, leaving it balanced to tight with less room to cover other markets.

  • Singapore’s exports fell for a second week, a slowdown that would further limit Asia’s spare supply if it continues as seasonal demand firms.


US Housing: The Lingering Curse of Poor Affordability Intensifies

By Said Desaque

  • The post-pandemic return of inflation and higher interest rates has had negative implications for US housing affordability. Rising mortgage rates since March have further dented the prospects for improved affordability.
  • Housing affordability has deteriorated to its lowest level since the 1980s. Apart from lower interest rates, better affordability will require future household income gains persistently outstripping home price appreciation.
  • Full federal government guarantees on Fannie Mae and Freddie Mac mortgage-backed securities would enhance housing affordability. Mortgage buydowns by homebuilders should be eliminated because they artificially boost market-clearing prices . 

Anatomy of a Canadian Bear

By Massif Capital Research

  • The S&P/TSX Composite has fallen 15% or more from a closing high sixteen times since 1979.
  • The average drawdown during those episodes was 27.6% over eight months; the median was 23.4% over six.
  • The gap is almost entirely the two structural bears, 2000-02 and 2008-09, which fell roughly 50% and took an average of 51 months to regain their peaks.

Middle East FX, October 9nd 2026

By Denis Collot

  • GCC sees record remittance outflows in 2025. Iraq devalues its currency by 15 %.

  • Saudi’s non-oil PMI rebounds strongly. Qatar partners with Euroclear for its local debt.

  • UAE, domestic credit grows at 15 % y/y in August.


CX Daily: Yuan’s Global Role Is Expanding Beyond Trade, StanChart Execs Say

By Caixin Global

  • Yuan’s Global Role Is Expanding Beyond Trade, StanChart Execs Say
  • The yuan is playing a growing role in cross-border trade and financing, but its global footprint remains limited, leaving substantial room to expand as Chinese companies deepen their overseas operations, Standard Chartered executives said at a recent forum in Singapore.
  • China Says It Has No Intention of Depreciating Yuan to Boost Exports

Morning Market Notes: Will The U.S.-Russia Diesel Deal Happen? Maybe Not

By William H Brown III

  • As we suspected, there are already what appear to be “cracks” in the U.S. deal for diesel, with Zelensky claiming that Russia has violated President Trump’s ceasefire on energy assets.
  • President Trump is also receiving significant “blowback” from both sides of the aisle, who are claiming that the deal violates the 2022 law prohibiting any aid to Putin’s war effort.  
  • As a result, and as we anticipated, NYMEX ULSD is experiencing a degree of “comeback” thus far, but we concede the jury remains out.

Oil futures: Crude higher as Mideast risk offsets Russia diesel release

By Quantum Commodity Intelligence

  • Crude oil futures were climbing higher on Monday as continued threats to Middle East crude flows helped offset expectations of additional Russian diesel supplies and a potential Russia-Ukraine energy ceasefire.
  • Front-month Dec26 ICE Brent futures were 1.4% higher at $106.17/b (2055 BST), while Nov26 NYMEX  WTI was at $93.27/b , up 1.6% versus Friday’s settle.
  • US President Donald Trump said Russia would supply an additional 500,000 tonnes of diesel in November and another 1 million tonnes “immediately thereafter,” following a supply deal with Moscow.

The First-Mile View on Commodities Making News (12 Oct 2026)

By Treefera

  • El Niño is the common thread in this edition, lifting raw sugar to an 19-month high and raising quality and flowering questions for Brazil coffee while West African cocoa waits on the rains.
  • In US grains, USDA’s 9 October report raised corn and soybean yields above trade expectations, sending December corn to $4.79¾, and first-mile data shows where supply risk sits inside the national totals.
  • US corn: Treefera Market Intelligence’s 7 October forecast put yield at 179.9 bu/ac, above the 177.7 bu/ac trade average, before USDA raised its estimate to 181.2.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Energy/Materials: Essential Minerals Acquisition, Northern Star Resources, Amerigo Resources , Crude Oil, Vale and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Primer: Essential Minerals Acquisition (ESMA US) – Oct 2026
  • Aussie Shorts [5th Oct 2026]: Wesfarmers , Northern Star Res., Pinnacle Investment, Alcoa, Lynas
  • Copper Continuing Consolidation At 14,500 USD/Ton: Our Idea Basket To Play Copper
  • Monday Macro Update: ULSD: The “Whipping Boy” Of The NYMEX
  • Essential Minerals Acquisition (ESMA US): Synthetic Expert Call Transcript (11 Oct 2026)
  • Iron Ore Prices: Small Bounce From 90 USD/Ton, Cost Pressures Still Negative For Equities


Primer: Essential Minerals Acquisition (ESMA US) – Oct 2026

By αSK Primers

  • Essential Minerals Acquisition Corp. (ESMA US) is a newly organized blank check company incorporated in the Cayman Islands, formed to execute a merger, share exchange, asset acquisition, or business combination targeting precious metals and critical minerals assets of strategic importance to the United States, primarily within Tier-1 jurisdictions including Nevada, Texas, Australia, and Canada.
  • The vehicle is structured around a $150.0 million initial public offering (15.0 million units at $10.00/unit, excluding the 2.25 million unit over-allotment option), featuring 100% gross proceeds collateralized in a US Treasury-backed trust account and a 1/8th Class A share right per unit, which eliminates traditional warrant exercise friction while reducing long-term capital overhang.
  • Led by junior mining and natural resource capital markets executives Matthew Hayes (Chairman/CEO) and Michael Loughnan (CFO), the company targets mid-market enterprises valued between $500.0 million and $1.5 billion; institutional assessment rests on de-SPAC execution probability, target asset quality, and managing 20% founder promote dilution against secular supply-chain reshoring tailwinds.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Aussie Shorts [5th Oct 2026]: Wesfarmers , Northern Star Res., Pinnacle Investment, Alcoa, Lynas

By David Blennerhassett


Copper Continuing Consolidation At 14,500 USD/Ton: Our Idea Basket To Play Copper

By Sameer Taneja


Monday Macro Update: ULSD: The “Whipping Boy” Of The NYMEX

By William H Brown III

  • NYMEX ULSD prices continue to succumb to government intervention, this time in response to President Trump’s deal for Russian diesel.     
  • We do not believe the agreement will have a sustainable impact on diesel prices over the next few months, however. The price impact of the G7 release was fleeting.            
  • In response to the Russian deal, we would anticipate that Ukraine will intensify its attacks against Russian refinery assets, despite President Trump’s call for a ceasefire on energy assets.                 

Essential Minerals Acquisition (ESMA US): Synthetic Expert Call Transcript (11 Oct 2026)

By αSK SmartScripts

  • Essential Minerals Acquisition Corp filed its S-1 registration statement in late August 2026, seeking to raise $150.0 million via 15.0 million units at $10.00 per unit to acquire critical and precious mineral assets in North America with enterprise values between $500.0 million and $1.5 billion.
  • The PIPE market for blank-check transactions in the natural resources sector remains highly constrained, requiring equity bridge structures, debt-like preferred instruments, or royalty monetization to fill 60.0% to 70.0% of total capital requirements for projects transitioning from feasibility to construction.
  • Long development lead times—averaging 12.0 to 15.0 years from initial discovery to commercial operation—force SPAC sponsors to bypass greenfield exploration assets in favor of advanced-stage, fully permitted domestic projects with existing Definitive Feasibility Studies (DFS).

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


Iron Ore Prices: Small Bounce From 90 USD/Ton, Cost Pressures Still Negative For Equities

By Sameer Taneja

  • It is hard to get constructive on iron ore due to poor lending data in China, with August TSF down 38% YoY, negative mill margins, and expectations of increased supply.
  • We believe, though, that we are now bumping up against the higher end of the cost curve as iron ore prices have drifted down to 90-91 USD/ton. 
  • While we see a small bounce in prices, we find it hard to be positive on equities, as elevated diesel and shipping costs are causing a margin squeeze.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief TMT/Internet: Shenzhen Transsion Holdings, SK Hynix, BASE Inc, Skyworth, TSMC (Taiwan Semiconductor Manufacturing), Jio Platforms Ltd, Biren Technology, Samsung Electronics and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • This Week in APAC ECM (Oct 4-10): Firmus Pulls ASX IPO; Moonshot Eyes USD 5bn; Jio Sets Price Band
  • October 7 MTD Reply: A Paradoxical Setup for Hynix
  • BASE (4477 JP): Maki-San Forces SBI’s Hand, but the Upside Is Largely Priced In
  • Merger Arb Mondays (12 Oct) – Skyworth, Z Fin, OFX, Ingenia/Peet, Cleanaway, Reliance, Kakaku
  • Transsion Holdings H Share Listing (2636 HK): Valuation Insights
  • TSMC 3Q26 Preview: 2027 Price Increases Should Hold Margins; Further Share Upside from Here
  • Jio Platforms IPO: Index Entry Timeline & Flow for India’s (Possibly) Largest IPO
  • Aequitas ECM Weekly (12 October 2026)-Wuxi Bio, CIG, CKD, Infroneer, JIO, ESWIN, Tinci, Transsion
  • Samsung Elec (005930 KS): Long 2x ETF Outflows Persist as Inverse Product Attracts Assets
  • The Blade Weekly: AI Chip Financings Pass US$150bn as OpenAI’s Revenue Lands US$20bn Below Reports


This Week in APAC ECM (Oct 4-10): Firmus Pulls ASX IPO; Moonshot Eyes USD 5bn; Jio Sets Price Band

By Ke Yan, CFA, FRM

  • Firmus pulled its USD 5.5bn ASX IPO. AS Watson’s USD 30bn dual listing was reportedly delayed to 2027, and Moonshot reportedly eyes an HK IPO of up to USD 5bn.
  • ESWIN, the week’s only HK listing, raised USD 319m and fell 1.0% on day one. Eight listings in the past month have a median return of -2.5% since IPO.
  • On HKEX, one company filed an AP and three posted PHIPs. Transsion’s USD 428m A+H IPO lists on 15 Oct.

October 7 MTD Reply: A Paradoxical Setup for Hynix

By Sanghyun Park

  • The MTD Reply may help Hynix secure dismissal, but its arguments on quarterly pricing upside and HBM’s outsized margins could reinforce peak out concerns and increase antitrust risk.
  • Chey appears to be pushing back against HBM peak out concerns by accelerating capex and reinforcing management’s confidence in sustained HBM and AI demand.
  • Hynix may accelerate ADR expansion ahead of the Solidigm IPO, using deeper US market ties as a shield against regulatory risk.

BASE (4477 JP): Maki-San Forces SBI’s Hand, but the Upside Is Largely Priced In

By Arun George

  • Maki-San likely holds around 28% of BASE Inc (4477 JP), targets over 30% via tender and no longer backs SBI. With shares 17% above terms, SBI cannot succeed at JPY340.
  • SBI likely needs JPY420–440 to beat a potential Maki tender. A token bump won’t work, so a small fill or walk-away may make more economic sense.
  • At the last close (JPY399), the risk/reward is unattractive. Based on a scenario analysis of the estimated prorated value, the upside is about 6% against a 12–20% downside.

Merger Arb Mondays (12 Oct) – Skyworth, Z Fin, OFX, Ingenia/Peet, Cleanaway, Reliance, Kakaku

By Arun George


Transsion Holdings H Share Listing (2636 HK): Valuation Insights

By Arun George


TSMC 3Q26 Preview: 2027 Price Increases Should Hold Margins; Further Share Upside from Here

By Vincent Fernando, CFA

  • 3Q26 revenue is already reported at NT$1,494.2bn, about US$46.7bn, 2% above the top of the guide; the 15 October release turns on margins, the 4Q guide and 2027.
  • We expect January 2027 price increases to roughly offset wider 2nm and overseas dilution, holding gross margin near 65-67%; 2027 capex is the bigger unknown.
  • Target price NT$2,920 (15% upside): 26.9x 2026 EPS, reflecting what we see as a permanent re-rating since 2019; TSMC trades at 17.9x 2027 earnings versus 23.0x for big US tech.

Jio Platforms IPO: Index Entry Timeline & Flow for India’s (Possibly) Largest IPO

By Brian Freitas

  • Jio Platforms is looking to list later this month by selling 270m shares at up to INR 1119/share, raising INR 302bn (US$3.1bn) and valuing the company at INR 10,305bn (US$106.5bn).
  • The small float (2.93% of shares out) will result in the stock missing Fast Entry to global indices. The pre-IPO lock-up expiry in April could result in global index inclusion.
  • Jio Platforms Ltd (1797135D IN) will be added to some local indices in March, though inclusion in the headline indices will need to wait till at least June.

Aequitas ECM Weekly (12 October 2026)-Wuxi Bio, CIG, CKD, Infroneer, JIO, ESWIN, Tinci, Transsion

By Sumeet Singh

  • Aequitas Research’s weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
  • On the IPO front, Jio Platforms is set to launch its US$3bn+ offering this week, while some listings continue to trickle through in Hong Kong. 
  • On the placement front, the HK flows picked up post the holidays and we had a look at a few of the upcoming lockup expiries.

Samsung Elec (005930 KS): Long 2x ETF Outflows Persist as Inverse Product Attracts Assets

By Gaudenz Schneider

  • Samsung Electronics (005930 KS) gained 3.3% in September and its 2x Leveraged Index rose 4.6%, while combined long-ETF AUM remained broadly steady, declining 0.9%.
  • All seven long-leveraged ETFs recorded unit redemptions, with net outflows reaching KRW 200bn in September and continuing in early October.
  • In contrast, the inverse ETF’s unit count rose 90% and AUM increased 62%, despite the product losing 14.7% in September.

The Blade Weekly: AI Chip Financings Pass US$150bn as OpenAI’s Revenue Lands US$20bn Below Reports

By Vincent Fernando, CFA

  • Financing plans for Anthropic, SpaceX and OpenAI chip orders totaled more than US$150bn, as the FT put OpenAI’s revenue run rate at about US$50bn.
  • Laminate and power chip prices rose, and Nanya told customers DRAM prices will rise up to 20% as Micron’s Taiwan union won a strike vote.
  • Foxconn booked Taiwan’s first NT$1tn revenue month and TSMC beat its 3Q guidance, while Samsung reportedly plans to cut 4Q phone output by up to 30%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Industrials: Nihon Dengi, Changzhou Microintelligence, GE Vernova , Tonbo Imaging and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Curator’s Cut: Debt Gets Dearer, Diesel Runs Dry & Strategic Stakes Come Undone
  • IPO Databook: Changzhou Microintelligence (HK) – Oct 2026
  • GE Vernova (GEV US): Synthetic Expert Call Transcript (12 Oct 2026)
  • Tonbo Imaging IPO: A Full-Stack Global Defence Electronics Platform
  • Changzhou Microintelligence (CZMI HK): Synthetic Expert Call Transcript (12 Oct 2026)


Curator’s Cut: Debt Gets Dearer, Diesel Runs Dry & Strategic Stakes Come Undone

By Pranav Rao

  • Welcome to Curator’s Cut – a fortnightly roundup of standout themes from the 1,200+ insights shared on Smartkarma.
  • In this cut, we look at who pays as yields climb, follow the squeeze in refined products, and track the unwinding of strategic stakes from Tokyo to Seoul and Singapore.
  • Want to dig deeper? Comment or message with the themes you’d like to see highlighted next.

IPO Databook: Changzhou Microintelligence (HK) – Oct 2026

By αSK IPO Databooks

  • Changzhou Microintelligence Co., Ltd. is an embodied intelligent industrial robotics company designing, developing, and commercializing industrial robots and solutions.
  • The company was the largest EIIR product provider in China in 2025 by revenue, with approximately 20.0% market share. It holds over 800 proprietary intellectual properties.
  • The company reported net profit of RMB22,528 thousand for five months ended May 31, 2026, but had accumulated losses of RMB142,706 thousand as of May 31, 2026.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


GE Vernova (GEV US): Synthetic Expert Call Transcript (12 Oct 2026)

By αSK SmartScripts

  • Electrification equipment pricing leverage has structurally inverted historical margin dynamics, pushing 1H 2026 segment EBITDA margins to 18.2% as high-voltage equipment scarcity allows GEV to pass through input inflation while expanding backlog gross margins.
  • Offshore wind tail risk remains under-reserved for structural mechanical fatigue, where current warranty provisions address known manufacturing lot defects (e.g., Gaspé blade bonding) but fail to capture potential fleet-wide blade root retrofits on the Haliade-X platform.
  • Gas Power slot reservations reaching 116 GW in Q2 2026 and customer advance payments drove a record $5.1 billion in single-quarter free cash flow, temporarily masking long-term utility working capital stretch through unprecedented upfront cash collection.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


Tonbo Imaging IPO: A Full-Stack Global Defence Electronics Platform

By Sudarshan Bhandari

  • Tonbo Imaging (TONBO IN) is building a Global Defence Electronics Business around electro-optics, thermal imaging, embedded computing and AI, with more than 28,000 systems deployed across 24 countries.
  • FY26 revenue stood at INR 362.6 crore, with EBITDA of INR 104.6 crore and a healthy 28.9% EBITDA margin
  • The bigger opportunity is the shift from individual thermal and tactical products towards integrated platform systems, backed by INR 314.1 crore of firm orders as of June 30, 2026

Changzhou Microintelligence (CZMI HK): Synthetic Expert Call Transcript (12 Oct 2026)

By αSK SmartScripts

  • EIIR transition drives margin expansion: Changzhou Microintelligence’s shift from traditional industrial automation hardware to Embodied Intelligent Industrial Robots (EIIR) increased its overall gross margin from 42.4% in 2023 to 48.4% in 2025, with high-margin EIIR units (gross margin 53.5% in 2025) now representing 57.0% of total revenue (RMB 453.3 million).
  • Payback threshold sits at 14–18 months: Industrial customers in 3C electronics and automotive require hard payback periods under 18 months and an IRR exceeding 25% before approving EIIR deployment; adoption is driven by labor cost replacement, defect reduction in high-precision assembly, and real-time yield optimization rather than general-purpose automation.
  • Operating cash flow inflection proves commercial viability: Net cash flow from operating activities swung from negative RMB 154.0 million in 2024 to positive RMB 141.0 million in 2025, alongside GAAP net profit rebounding to RMB 22.5 million in the first five months of 2026, confirming that upfront R&D investments (RMB 235.0 million in 2025) are yielding scalable software-hardware leverage.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Health Care: Wuxi Biologics, Jiangsu Hengrui Pharmaceuticals, Nexalin Technology , BirchBioMed, City Therapeutics and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Wuxi Biologics (2269 HK) Placement – Thought on Valuation and the Outlook
  • Jiangsu Hengrui Pharmaceuticals (1276 HK): Big Fat Obesity Pipeline Is At Inflection Point
  • Nexalin Technology (NXL US): Synthetic Expert Call Transcript (11 Oct 2026)
  • IPO Databook: BirchBioMed (BRBM US) – Oct 2026
  • IPO Databook: City Therapeutics (CTY US) – Oct 2026


Wuxi Biologics (2269 HK) Placement – Thought on Valuation and the Outlook

By Xinyao (Criss) Wang

  • WuXi Bio launched a Placement,aiming to raise up to US$500mn.After a significant surge, selling shares at this share price level indicates a feature of cashing out at a high price. 
  • Based on HK$51.77-52.31 and 2026 forecast, P/E is 32-33x, higher than our estimate 25-30x P/E.This means the market has already priced in most of growth for WuXi Bio this year.
  • Although Wuxi’s affiliated companies have demonstrated solid fundamentals and signs of valuation recovery since 2025, the share reduction by major shareholders has still weakened market confidence in their long-term value

Jiangsu Hengrui Pharmaceuticals (1276 HK): Big Fat Obesity Pipeline Is At Inflection Point

By Tina Banerjee

  • Jiangsu Hengrui Pharmaceuticals (1276 HK) entered into a license agreement with Novo Nordisk for obesity drug candidate HRS-1596, with potential for once-weekly oral dosing for total deal value of $2.6B.
  • The company is expected to launch GLP-1/GIP injectable ribupatide (HRS9531) in early 2027. If launched, injectable ribupatide will be third drug of its class in China market.
  • With near-to-market GLP-1 anchor assets, Hengrui is ready to build a leading obesity franchise in China. Although obesity market is competitive, China market is large enough to accommodate multiple players.

Nexalin Technology (NXL US): Synthetic Expert Call Transcript (11 Oct 2026)

By αSK SmartScripts

  • Commercial traction remains constrained by zero insurance reimbursement and low volume, with Q2 2026 revenue printing at just $12.16 thousand despite international distribution agreements.
  • The company faces an acute balance sheet wall: with roughly $1.0 million in cash as of mid-2026 against a quarterly cash burn of $1.7 million to $1.8 million, raising capital is an immediate operational requirement.
  • While Nasdaq minimum bid price compliance was restored in October 2026 via a 1-for-30 reverse stock split, the business must satisfy Nasdaq’s $2.5 million stockholders’ equity requirement by January 4, 2027, forcing near-term dilutive equity or non-dilutive licensing choices.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


IPO Databook: BirchBioMed (BRBM US) – Oct 2026

By αSK IPO Databooks

  • BirchBioMed Inc. is a clinical stage biopharmaceutical company developing treatments for scarring, skin disorders, autoimmune diseases, and organ fibrosis.
  • BirchBioMed completed a Phase 1 clinical trial for FS2 in 2018 and received U.S. FDA Orphan Drug Designation for FS2 in November 2025.
  • The company reported cash and cash equivalents of $3,086,484 as of June 30, 2026, alongside a net loss of $(1,249,402) for the six months then ended.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


IPO Databook: City Therapeutics (CTY US) – Oct 2026

By αSK IPO Databooks

  • City Therapeutics, Inc. is a clinical-stage biotechnology company developing RNA interference therapeutics to silence disease-relevant proteins, leveraging its City Platform.
  • City Therapeutics advanced three programs into or toward the clinic since July 2023, with CITY-FXI Phase 1 data showing 85% FXI knockdown.
  • The company reported collaboration revenue of $6,358 thousand for six months ended June 30, 2026, alongside a net loss of $(53,443) thousand.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Financials: Wharf Real Estate Investment Company, Lendela , US 2Y, Calm Seas Acquisition, SBI Funds Management, Westpac Banking and more

By | Daily Briefs, Financials

In today’s briefing:

  • The Great Hong Kong Retail Short Wharf REIC 1997 HK: Capitalizing on Structural Decline
  • Lendela: Scaling a Loan-Matching Platform from Singapore (Initiation)
  • Learnings from Two Short-Dollar Positions in an Oil Crisis
  • Calm Seas Acquisition (CSEA US): Synthetic Expert Call Transcript (11 Oct 2026)
  • Primer: SBI Funds Management (SBIFUNDS IN) – Oct 2026
  • Australia: Relative Value Opportunities and Pair Trades (12 Oct 2026)


The Great Hong Kong Retail Short Wharf REIC 1997 HK: Capitalizing on Structural Decline

By Jacob Cheng

  • Structural retail decay from Shenzhen consumption leakage makes Hong Kong commercial property a prime macro short opportunity.
  • Wharf REIC offers an institutional-grade, highly liquid vehicle with cheap borrow rates to short this trend safely.
  • While PBOC stimulus poses tactical risks, expanding cap rates and permanent shifts in consumer behaviour ensure long-term valuation overhangs.

Lendela: Scaling a Loan-Matching Platform from Singapore (Initiation)

By Ben Lim

  • Regional Loan Matchmaking Platform: Lendela operates a digital consumer finance platform across Singapore and Hong Kong, utilising a reverse-auction model to connect retail borrowers with over 100 licensed financial institutions. The company has processed more than 500,000 loan applications since inception, acting as an asset-light intermediary that centralises credit access without holding loans on its own balance sheet.
  • Rapid Top-Line Expansion: The core value driver rests on the platform’s ability to generate high-intent borrower leads, which drove revenue from US$1.9m in FY22 to US$5.2m in FY24. This growth is underpinned by proprietary API integrations with lenders and national identity systems, creating a scalable business model that monetises exclusively through successful loan disbursements.
  • Structurally Negative Unit Economics: The company relies heavily on expensive paid advertising channels to drive consumer traffic, resulting in a complete absence of near-term operating leverage. This high customer acquisition cost drove a widening net loss of US$2.3m in FY24; although the loss narrowed in FY25, continued cash outflows from a year-end FY24 cash balance of US$2.4m make further external capital likely to be required.

Learnings from Two Short-Dollar Positions in an Oil Crisis

By Ishaan Dev Kapoor

  • The EUR/USD seagull was salvaged at 3 pips against 19.5 paid after the 16 September hike, having been marked +181% on 21 August. The USD/INR short expired flat at 95.98.
  • The euro trade paid on fiscal dominance, not the US front end we entered on. We overrode the Iran exit rule because we read misread a three-week regime
  • FCNR carried the INR through a 20% rise in oil, but faltered as prices soared 37%. We still see US disinflation in the data, and think 3 hikes are rich.

Calm Seas Acquisition (CSEA US): Synthetic Expert Call Transcript (11 Oct 2026)

By αSK SmartScripts

  • Calm Seas Acquisition Corp. revised its SPAC IPO structure in October 2026 to target $200 million (20,000,000 units at $10.00 per unit), supported by a $25 million Forward Purchase Agreement from Pilgrim Global ICAV to secure baseline execution capital.
  • The vehicle focuses on acquiring hard-asset energy and maritime targets in the $500 million to $5 billion enterprise value range, aiming to exploit supply constraints in offshore drilling, specialized logistics, and maritime infrastructure.
  • Structural redemption risks are directly addressed through sponsor-aligned equity backstops, a 15% public shareholder redemption cap, and an 18-month transaction timeline designed to enforce strict valuation discipline against competing private equity bidders.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


Primer: SBI Funds Management (SBIFUNDS IN) – Oct 2026

By αSK Primers

  • Market Scale and Unrivaled Lineage: SBI Funds Management Limited (SBIFML) is India’s largest asset management company with approximately 15% mutual fund market share and industry-leading total AUM, anchored by the formidable backing of State Bank of India’s 22,000+ branch distribution footprint and Amundi’s global institutional asset management capabilities.
  • Superior Operating Margins and Cash Conversion: Demonstrating elite operating leverage, SBIFML expanded FY26 revenue by 21.1% YoY to INR 45,556.45m and net income by 20.8% YoY to INR 30,673.76m, sustaining world-class net margins of 67.33% and converting over 86% of net earnings into free cash flow to equity (INR 26,491.25m in FY26).
  • Yield Dilution vs. Expansion Catalysts: While headline AUM scale is amplified by dominant institutional mandates such as the Employees’ Provident Fund Organisation (EPFO), these low-fee mandates dilute blended realization yields relative to pure-play retail equity peers; medium-term rerating hinges on accelerating high-margin active equity, systematic investment plan (SIP) penetration in B-100 cities, and scaling high-alpha Alternative Investment Funds (AIFs).

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Australia: Relative Value Opportunities and Pair Trades (12 Oct 2026)

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlights: In Australia, currently two pair trade opportunities persist across two sectors.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Smartkarma The Investment Intelligence Platform

Daily Brief Consumer: Hyundai Motor India, Secretlab, Mcdonald’s Japan, Sheng Siong, F45 Training Holdings , Temple & Webster Group Ltd, TSE Tokyo Price Index TOPIX and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Hyundai Motor India: From a Disrupted Q1 to Record Q2 Volumes — Can the 2030 Roadmap Rebuild Growth?
  • Secretlab: Cash-Generative Growth Beyond Gaming (Initiation)
  • McDonald Japan (2702): Higher Margin but Cheaper than Peers
  • Sheng Shiong (SSG) Vs. Kimly: Convergence
  • Primer: F45 Training Holdings (FXLV US) – Oct 2026
  • Temple & Webster Group Ltd – Joyce Corp’s Capital Light Growth In Focus
  • What Do Managers Realize After Going Private?


Hyundai Motor India: From a Disrupted Q1 to Record Q2 Volumes — Can the 2030 Roadmap Rebuild Growth?

By Nimish Maheshwari

  • After a difficult Q1 FY27, Hyundai delivered 219,072 wholesale units in July–September 2026, up 23.0% sequentially, including a company-record 77,916 units in September.
  • The rebound reflects normalized production and healthier domestic momentum after supplier fire caused a loss of approximately 13,900 units of June production. Nevertheless, Q2 sales disclosures establish volumes, not profitability.
  • Short-Term execution risk has diminished, but investment conviction depends on margins recovering toward FY27 guidance and on tangible delivery against the company’s FY2030 SUV, alternative-powertrain, localisation and revenue targets.

Secretlab: Cash-Generative Growth Beyond Gaming (Initiation)

By Beier Luo

Executive Summary

  • Global Direct-to-Consumer Brand: Secretlab has grown from a niche esports chair maker into a mainstream ergonomic furniture brand, selling to customers worldwide through its own regional online stores. Designing products in-house and selling directly lets it bypass retail intermediaries, keep the full margin, and control its brand, while expanding from gaming chairs into desks, accessories, and, more recently, office task seating.
  • Self-Funded and Cash Generative: The business has relied very little on outside equity since its founding and has returned to profitability with a net cash balance sheet. Its asset-light model, with minimal fixed assets and customer prepayments funding part of its working capital, allows it to fund product development internally.
  • Inventory and Supply Chain Exposure: Because Secretlab owns its stock and ships bulky goods worldwide, it is highly sensitive to freight costs and demand swings. An aggressive inventory build after the pandemic boom, funded partly with short-term bank debt, compressed margins and led to a loss as excess stock was cleared.

McDonald Japan (2702): Higher Margin but Cheaper than Peers

By Henry Soediarko

  • Mcdonald’s Japan (2702 JP) is Japan’s defensive, high-quality QSR name in Japan with a defensible moat. 
  • Minimal impact from volatility in tourist arrivals, as most of the outlets are in the suburban areas; therefore, it is truly a domestic consumption story. 
  • McDonald Japan’s operating profit margin is double that of Zensho and Skylark (which comes from operational discipline and price hike), while its PER is still lower, which is the opportunity 

Sheng Shiong (SSG) Vs. Kimly: Convergence

By Henry Soediarko

  • Sheng Siong (SSG SP) benefited from the SG60 cash handouts and expanded CDC (spending voucher) disbursement. 
  • As growth plateaus and there are better stocks out there to offer yield and return, investors are likely to rotate out; hence, the 28x PER will normalize to 18-20x. 
  • Investors could either do a short Sheng Shiong or sell their existing holdings to book profit. Another way is to pair this with Kimly (KMLY SP)with 2% positive yield. 

Primer: F45 Training Holdings (FXLV US) – Oct 2026

By αSK Primers

  • Severe Operational Retrenchment and Revenue Contraction: After an aggressive global expansion culminating in an initial public offering in July 2021, F45 Training Holdings Inc. (FXLV) encountered severe operational and financial dislocation. Full-year FY2022 revenue contracted 22.1% year-over-year to $104.42M (down from $134.02M in FY2021) as third-party franchisee financing facilities collapsed, new studio delivery stalled, and extensive accounting restatements revealed widespread premature revenue recognition.
  • Acute Solvency Distress, Dilution Overhang, and NYSE Delisting: The company reported massive net losses of -$178.80M in FY2022 and -$182.72M in FY2021, driven by negative operating cash flows (-$96.78M in FY2022) and free cash flow burn of -$103.30M. This liquidity strain prompted emergency debt restructurings, executive turnover, internal control failures, and a voluntary delisting from the New York Stock Exchange in August 2023 to the over-the-counter Expert Market tier, virtually eliminating institutional liquidity.
  • Distressed Turnaround Pivot Under New Brand Leadership: Operating under new Chief Executive Officer Tom Dowd and Chief Brand Officer Mark Wahlberg, F45 is attempting a stabilization strategy focused on unit-level franchisee economics, recurring royalty cash generation, overhead rationalization, and brand extensions such as FS8 (Pilates/Yoga). However, extreme balance sheet debt, ongoing litigations, and lingering franchisee attrition limit near-term institutional investability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Temple & Webster Group Ltd – Joyce Corp’s Capital Light Growth In Focus

By FNArena

  • Combining resilient trading, a capital-light business model and an attractive dividend yield, Joyce Corp also offers a long growth runway.
  • Joyce’s capital light business model provides strong cash flows Minimal maintenance capex leaves room for dividends Expansion potential at KWB Group, the main growth engine Exposed to housing activity and consumer sentiment

What Do Managers Realize After Going Private?

By Aki Matsumoto

  • The elimination of “parent-subsidiary listings” in the broad sense—including affiliated companies—and delistings resulting from TOBs etc. that lead to industry consolidation are expected to improve the profitability of listed companies.
  • After delisting, a company will have no choice but to break away from management style that defers challenges to work toward improving earnings in line with the fund’s profit targets.
  • After a company is delisted, some executives may realize for the first time that maximizing shareholder interests is the primary management objective of a corporation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars